Kim JJ, Němec J, Papp R, Strongin R, Abramson JJ, Salama G. Bradycardia alters Ca 2ϩ dynamics enhancing dispersion of repolarization and arrhythmia risk. Am J Physiol Heart Circ Physiol 304: H848 -H860, 2013. First published January 11, 2013; doi:10.1152/ajpheart.00787.2012.-Bradycardia prolongs action potential (AP) durations (APD adaptation), enhances dispersion of repolarization (DOR), and promotes tachyarrhythmias. Yet, the mechanisms responsible for enhanced DOR and tachyarrhythmias remain largely unexplored. Ca 2ϩ transients and APs were measured optically from Langendorff rabbit hearts at high (150 ϫ 150 m 2 ) or low (1.5 ϫ 1.5 cm 2 ) magnification while pacing at a physiological (120 beats/min) or a slow heart rate (SHR ϭ 50 beats/min). Western blots and pharmacological interventions were used to elucidate the regional effects of bradycardia. As a result, bradycardia (SHR 50 beats/min) increased APDs gradually (time constant f¡s ϭ 48 Ϯ 9.2 s) and caused a secondary Ca 2ϩ release (SCR) from the sarcoplasmic reticulum during AP plateaus, occurring at the base on average of 184.4 Ϯ 9.7 ms after the Ca 2ϩ transient upstroke. In subcellular imaging, SCRs were temporally synchronous and spatially homogeneous within myocytes. In diastole, SHR elicited variable asynchronous sarcoplasmic reticulum Ca 2ϩ release events leading to subcellular Ca 2ϩ waves, detectable only at high magnification. SCR was regionally heterogeneous, correlated with APD prolongation (P Ͻ 0.01, n ϭ 5), enhanced DOR (r ϭ 0.9277 Ϯ 0.03, n ϭ 7), and was gradually reversed by pacing at 120 beats/min along with APD shortening (P Ͻ 0.05, n ϭ 5). A stabilizer of leaky ryanodine receptors (RyR2), 3-(4-benzylcyclohexyl)-1-(7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepin-4(5H)-yl)propan-1-one (K201; 1 M), suppressed SCR and reduced APD at the base, thereby reducing DOR (P Ͻ 0.02, n ϭ 5). Ventricular ectopy induced by bradycardia (n ϭ 5/15) was suppressed by K201. Western blot analysis revealed spatial differences of voltage-gated L-type Ca 2ϩ channel protein (Cav1.2␣), Na ϩ -Ca 2ϩ exchange (NCX1), voltage-gated Na ϩ channel (Nav1.5), and rabbit ether-a-go-go-related (rERG) protein [but not RyR2 or sarcoplasmic reticulum Ca 2ϩ ATPase 2a] that correlate with the SCR distribution and explain the molecular basis for SCR heterogeneities. In conclusion, acute bradycardia elicits synchronized subcellular SCRs of sufficient magnitude to overcome the source-sink mismatch and to promote afterdepolarizations. action potential adaptation; arrhythmia; bradycardia; optical mapping; secondary Ca 2ϩ release BRADYCARDIA, DEFINED AS heart rate (HR) Ͻ 60 beats/min in adult humans (12), is usually a normal adaptive response to conditions of low metabolic demand, such as rest and sleep. Bradycardia due to pathological conditions, e.g., sick sinus syndrome, atrioventricular (AV) nodal disease, or conduction system disease, is common in clinical practice and frequently causes symptoms because of inappropriately low cardiac output. Less frequently, profound bradycardia, usuall...